Statistics for Laboratorios Farmaceuticos Rovi SA (id:4678 ROVI)

Valuation metrics

Market cap

3.18B

Enterprise value

3.30B

Trailing P/E (ttm)

19.56

Forward P/E

22.95

PEG ratio

22.95

Price/Sales (ttm)

3.98

Price/Book (mrq)

6.05

Enterprise Value/Revenue

4.13

Enterprise Value/EBITDA

14.12

Overview

Shares outstanding

51.15M

Float

18.61M

Shares short

% Held by insiders

0.63%

% Held by institutions

0.19%

Average volume (10 days)

166.90K

Average volume (90 days)

Price summary

52-Week low

52.65

52-Week high

94.80

52-Week change

13.14%

Beta

0.48

50-Day moving average

73.48

200-Day moving average

79.31

Dividends and splits

Forward annual dividend rate

4.41

Forward annual dividend yield

0.07

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

0.86

Payout ratio

0.35

Dividend date

Ex-dividend date

July 08th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

20.64%

Operating margin

38.28%

Operational effectiveness

Return on assets

15.55%

Return on equity

29.65%

Income statement

Revenue (ttm)

14.97

Revenue per share (ttm)

14.97

Quarterly revenue growth (yoy)

0.32

Gross profit (ttm)

492.28M

EBITDA

217.77M

Net income to common (ttm)

165.00M

Diluted EPS (ttm)

3.18

Quarterly earnings growth (yoy)

32.50%

Balance sheet

Total cash (mrq)

17.55M

Total cash per share (mrq)

0.34

Total debt (mrq)

128.28M

Total Debt/Equity (mrq)

22.98

Current ratio (mrq)

250.00%

Book value per share (mrq)

10.28

Cash flow

Cash flow statement

126.18M

Levered free cash flow (LFCF)

48.54M